Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 551-560 of 2855 for cancer

Edit search filters
  1. Cyclophosphamide and Vaccine Therapy in Treating Patients with Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Rochester, MN

  2. A Study To Evaluate Wound Infiltration With Liposomal Bupivacaine In Laparotomy For Gynecological Malignancy

    Rochester, MN

  3. A Study Of Enfortumab Vedotin Alone Or With Other Therapies For Treatment Of Urothelial Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. A Study to Analyze CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma

    Scottsdale/Phoenix, AZ

  5. SX-682 Treatment In Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

    Rochester, MN

  6. BCG In Combination With Durvalumab In Adult BCG-naïve, High-risk NMIBC Participants (PATAPSCO)

    Scottsdale/Phoenix, AZ

  7. A Study of Combination Chemotherapy for Treating Women with Stage II or Stage IIIA Breast Cancer that has Spread to the Lymph Nodes

    Eau Claire, WI

  8. A Dose Escalation Study Of Amivantamab In Participants With Advanced Non-Small Cell Lung Cancer

    Rochester, MN

  9. A Study To Test The Addition Of Berzosertib To Usual Radiation Treatment For Chemotherapy-Resistant Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, And Cyclophosphamide In Treating Patients With Triple Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer